Welcome to LookChem.com Sign In|Join Free

CAS

  • or

105757-72-0

Post Buying Request

105757-72-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

105757-72-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 105757-72-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,5,7,5 and 7 respectively; the second part has 2 digits, 7 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 105757-72:
(8*1)+(7*0)+(6*5)+(5*7)+(4*5)+(3*7)+(2*7)+(1*2)=130
130 % 10 = 0
So 105757-72-0 is a valid CAS Registry Number.

105757-72-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-(4-methylpyridin-1-ium-1-yl)-1-phenylethanone,chloride

1.2 Other means of identification

Product number -
Other names 1-phenacyl-4-methylpyridinium chloride

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:105757-72-0 SDS

105757-72-0Relevant articles and documents

Synthesis and biological evaluation of a new series of N-ylides as protein farnesyltransferase inhibitors

Abuhaie, Cristina-Maria,Ghinet, Alina,Farce, Amaury,Dubois, Jo?lle,Rigo, Beno?t,B?cu, Elena

, p. 5887 - 5892 (2013)

A new family of 30 benzoylated N-ylides 4 and 5 was synthesized and evaluated for the inhibitory activity on human protein farnesyltransferase. Most of these novel compounds possessed in vitro inhibition potencies in the micromolar range. The nature of th

Oral Hypoglycemic Agents. Discovery and Structure-Activity Relationships of Phenacylimidazolium Halides

Dominianni, Samuel J.,Yen, Terence T.

, p. 2301 - 2306 (2007/10/02)

Blood glucose levels in viable, yellow, obese, diabetic mice are reduced following oral administration of phenacylimidazolium halides.Compounds 2 and 3 produced reductions of ca. 40percent 2 h after doses of 100 mg/kg po.Since these mice do not respond to sulfonylureas, the glucose-lowering activity of phenacylimidazolium salts in this model suggests a mechanism other than that of stimulating insulin secretion.Only phenacylimidazolium halides with electron-donating groups were active; other azolium salts or variations in the phenacyl portion (alterations in the keto function; chain lengthening or extensive branching) produced inactive compounds.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 105757-72-0